Polar Asset Management Partners Inc. Vaxcyte, Inc. Transaction History
Polar Asset Management Partners Inc.
- $3.16 Billion
- Q2 2024
A detailed history of Polar Asset Management Partners Inc. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 98,200 shares of PCVX stock, worth $11.1 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
98,200
Previous 104,479
6.01%
Holding current value
$11.1 Million
Previous $7.14 Million
3.91%
% of portfolio
0.23%
Previous 0.16%
Shares
7 transactions
Others Institutions Holding PCVX
# of Institutions
286Shares Held
110MCall Options Held
248KPut Options Held
109K-
Black Rock Inc. New York, NY9.94MShares$1.12 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.8MShares$1.11 Billion0.01% of portfolio
-
Janus Henderson Group PLC London, X08.87MShares$1 Billion0.37% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.2MShares$928 Million9.34% of portfolio
-
Wellington Management Group LLP Boston, MA4.59MShares$519 Million0.06% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $6.71B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...